Hudson Bay Capital Management LP Arrowhead Pharmaceuticals, Inc. Transaction History

Hudson Bay Capital Management LP

$28.9 Billion
Q1 2025

A detailed history of Hudson Bay Capital Management LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 213,130 shares of ARWR stock, worth $3.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

213,130

Previous 175,000 21.79%

Holding current value

$3.32 Million

Previous $3.29 Million 17.48%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$12.74 - $21.53 $485,776 - $820,938	38,130 Added 21.79%	213,130 $2.72 Million
Q4 2024 Feb 14, 2025	SELL	$17.7 - $26.34 $796,500 - $1.19 Million	-45,000 Reduced 20.45%	175,000 $3.29 Million
Q3 2024 Nov 13, 2024	BUY	$19.36 - $29.54 $774,400 - $1.18 Million	40,000 Added 22.22%	220,000 $4.26 Million
Q2 2024 Aug 14, 2024	BUY	$21.87 - $28.24 $984,150 - $1.27 Million	45,000 Added 33.33%	180,000 $4.68 Million
Q1 2024 May 15, 2024	SELL	$27.21 - $39.48 $2.91 Million - $4.22 Million	-106,807 Reduced 44.17%	135,000 $3.86 Million
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $1.73 Million - $2.54 Million	81,807 Added 51.13%	241,807 $7.4 Million
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $1.24 Million - $1.71 Million	47,500 Added 42.22%	160,000 $4.3 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $880,600 - $1.45 Million	-35,000 Reduced 23.73%	112,500 $4.01 Million
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $3.49 Million - $5.68 Million	147,500 New	147,500 $3.75 Million
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $933,299 - $1.7 Million	-33,584 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $1.33 Million - $2.35 Million	33,584 New	33,584 $1.55 Million
Q3 2020 Nov 12, 2020	SELL	$33.21 - $51.27 $1.16 Million - $1.79 Million	-35,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$26.12 - $43.27 $914,200 - $1.51 Million	35,000 New	35,000 $1.51 Million
Q1 2019 May 15, 2019	SELL	$12.05 - $20.18 $361,500 - $605,400	-30,000 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$10.74 - $19.7 $322,200 - $591,000	30,000 New	30,000 $373,000

Others Institutions Holding ARWR

# of Institutions

300

Shares Held

98M

Call Options Held

306K

Put Options Held

432K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.65B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Arrowhead Pharmaceuticals, Inc. Transaction History